Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis

Part of paid clinical trials in Abbott Park, Illinois.

Sponsor
Abbott
Study ID
NCT00195689
Phase
PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of the study is to assess the long-term safety and clinical efficacy of adalimumab in treatment of moderate to severely active psoriatic arthritis

Key Dates

Start date
Aug 31, 2003
Status verified
Aug 2007

Study Design

Enrollment
400 participants
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

Safety parameters

Locations (1)

FacilityCityStateZIPSite coordinators
Global Medical Information-Abbott LaboratoriesAbbott ParkIllinois60064-

Find similar trials in Abbott Park, IL

By condition
Psoriatic arthritis
By specialty
RheumatologyAutoimmune diseaseMusculoskeletal disorders
By research site
Global Medical Information-Abbott Laboratories· Abbott Park, IL

Related Studies